GDR — Genedrive Income Statement
0.000.00%
Last trade - 00:00
- £8.77m
- £7.67m
- £0.06m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.36 | 1.06 | 0.687 | 0.049 | 0.055 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.37 | 6.7 | 6.17 | 5.66 | 5.28 |
Operating Profit | -4.01 | -5.64 | -5.48 | -5.62 | -5.22 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.52 | -20.4 | -1.85 | -5.63 | -5.98 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.64 | -19.4 | -0.691 | -4.67 | -5.15 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.64 | -19.4 | -0.691 | -4.67 | -5.15 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.64 | -19.4 | -0.691 | -4.67 | -5.15 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.149 | -0.541 | -0.012 | -0.055 | -0.055 |